ClinicalTrials.govpublic full text
Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Cancers
pancreatic cancer, gastric cancer, claudin 18.2 adc, phase 1, cpo102, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 853918
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.